Sharing Called Rx for U.S.-Japan Tensions

WASHINGTON—American companies can learn a great deal from the Japanese approach to research planning and the contribution it makes to productivity, a group of U.S. research directors have concluded after a visit there last fall. But the two countries stand to gain even more from a full and continuous exchange of information, suggest a second group of American and Japanese officials that is in the midst of an extended discussion on issues of scientific collaboration. "In all of Japanese ind

Written byCarol Turkington
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

But the two countries stand to gain even more from a full and continuous exchange of information, suggest a second group of American and Japanese officials that is in the midst of an extended discussion on issues of scientific collaboration.

"In all of Japanese industry there was unquestionably the feeling that technology is the root that supports the company tree," explained Thomas J. Savereide, director of 3M's Central Research Labs in St. Paul, Minn. who led 25 research directors on a tour of several Japanese companies last fall in an effort to learn how that country manages to translate research results into successful products. "The roots were well watered and taken care of."

The trip was sponsored by the Industrial Research Institute, a New York-based association of 265 major industrial corporations. The Institute held a press conference here last month to publicize its findings.

"We have to create new techniques ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies